RLMD

#2619
Relmada Therapeutics, Inc. Common Stock
7.35 USD
-0.41%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
7.34
7.39
Year Range
0.27
7.94
Daily Change
-0.41%
Monthly Change
+22.91%
6 month change
+280.83%
Year Change
+2350.00%
Previous Close
7.38
Open
7.38
Bid
Ask
Low
7.34
High
7.39
Volume
139
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 770.94 M
  • Employee 17
  • Founded 2004
  • CEO N/A
  • Website www.relmada.com
  • Headquarter Nevada, United States
  • FIGI BBG003MKSL16
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.33
Price to sales ratio
-2 407.45

News